Related Experiment Video

Updated: Jun 6, 2026

Establishment and Confirmation of a Postnatal Right Ventricular Volume Overload Mouse Model
06:04

Establishment and Confirmation of a Postnatal Right Ventricular Volume Overload Mouse Model

Published on: June 9, 2023

Left ventricular non compaction in children

Sara H Weisz1, Giuseppe Limongelli, Giuseppe Pacileo

  • 1Department of Cardiology, Second University of Naples, Monaldi Hospital, Naples, Italy.

Congenital Heart Disease
|November 20, 2010
PubMed

Insights

Left ventricular non compaction (LVNC) is a heart muscle condition with deep recesses in the left ventricle, increasing clot risk. This review focuses on sparse data regarding childhood LVNC cases.

Area of Science:

  • Cardiology
  • Developmental Biology
  • Genetics

Background:

  • Left ventricular non compaction (LVNC) is a myocardial disease defined by a hypertrabeculated left ventricular wall.
  • Deep recesses in the myocardium increase the risk of blood clot formation.
  • While adult LVNC is studied, data on childhood LVNC is limited.

Purpose of the Study:

  • To review and summarize current clinical and preclinical knowledge of LVNC specifically in children.
  • To highlight the sparse data available on pediatric LVNC.
  • To consolidate information for better understanding and management of childhood LVNC.

Main Methods:

  • Literature review of clinical and preclinical studies on LVNC.
  • Focus on studies reporting on pediatric populations.
  • Synthesis of findings related to diagnosis, presentation, and outcomes in children.

Main Results:

  • LVNC presents with a hypertrabeculated myocardium, particularly affecting the left ventricular apex and free wall.
  • The condition is likely due to premature interruption of normal heart development, specifically myocardial compaction.
  • Existing research on pediatric LVNC is sparse, necessitating further investigation.

Conclusions:

  • Understanding the developmental origins of LVNC is crucial.
  • Further research is essential to address the paucity of data on childhood LVNC.
  • Consolidating existing knowledge is a key step towards improving diagnosis and management in pediatric patients.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...